Novel SNP improves differential survivability and mortality in non-small cell lung cancer patients

BACKGROUND: Non-small cell lung cancer (NSCLC) is a major cause of cancer-related death worldwide due to poor patient prognosis and clinical outcome. Here, we studied the genetic variations underlying NSCLC pathogenesis based on their association to patient outcome after gemcitabine therapy. RESULTS...

Descripción completa

Detalles Bibliográficos
Autores principales: Mah, Tzia Liang, Yap, Xin Ning Adeline, Limviphuvadh, Vachiranee, Li, Nanpu, Sridharan, Srinath, Kuralmani, Vellaisemy, Feng, Mengling, Liem, Natalia, Adhikari, Sharmila, Yong, Wei Peng, Soo, Ross A, Maurer-Stroh, Sebastian, Eisenhaber, Frank, Tong, Joo Chuan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2014
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4290611/
https://www.ncbi.nlm.nih.gov/pubmed/25521664
http://dx.doi.org/10.1186/1471-2164-15-S9-S20

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4290611/
https://www.ncbi.nlm.nih.gov/pubmed/25521664
http://dx.doi.org/10.1186/1471-2164-15-S9-S20

Ejemplares similares